Bromocriptine mesylate (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Bromocriptine mesylate drug offered from Cadila Healthcare Limited. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Bromocriptine mesylate |
SUBSTANCE NAME: | BROMOCRIPTINE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-01-23 |
END MARKETING DATE: | 0000-00-00 |
Bromocriptine mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Bromocriptine mesylate from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2009-01-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-654_9af9a5a6-222c-4d59-808a-f9e2fdf5bf89 |
PRODUCT NDC: | 65841-654 |
APPLICATION NUMBER: | ANDA078899 |
Other BROMOCRIPTINE MESYLATE Pharmaceutical Manufacturers / Labelers: